Literature DB >> 30366798

Dry Eye Syndrome Preferred Practice Pattern®.

Esen K Akpek1, Guillermo Amescua2, Marjan Farid3, Francisco J Garcia-Ferrer4, Amy Lin5, Michelle K Rhee6, Divya M Varu7, David C Musch8, Steven P Dunn9, Francis S Mah10.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30366798     DOI: 10.1016/j.ophtha.2018.10.023

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  26 in total

1.  Effects of topical low-dose preservative-free hydrocortisone on intraocular pressure in patients affected by ocular surface disease with and without glaucoma.

Authors:  M Filippelli; R dell'Omo; A Gelso; M Rinaldi; S Bartollino; P Napolitano; A Russo; G Campagna; C Costagliola
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-18       Impact factor: 3.117

2.  The Effect and the Mechanism of Comprehensive Treatment on the Ocular Surface and the Visual Quality of Online Teachers with a Mild-to-Moderate Dry Eye Condition During the Early Phase of Coronavirus Disease 2019.

Authors:  Yan-Xi Wang; Gang-Jin Kang; Juan Zhou; Kai-Ming Li; Man-Hua Xu
Journal:  Int J Gen Med       Date:  2021-10-14

3.  Functionalized Hyaluronic Acid for "In Situ" Matrix Metalloproteinase Inhibition: A Bioactive Material to Treat the Dry Eye Sydrome.

Authors:  Susi Burgalassi; Marco Fragai; Oscar Francesconi; Linda Cerofolini; Daniela Monti; Gemma Leone; Stefania Lamponi; Giuseppe Greco; Agnese Magnani; Cristina Nativi
Journal:  ACS Macro Lett       Date:  2022-09-14       Impact factor: 7.015

4.  Hyperosmolarity disrupts tight junction via TNF-α/MMP pathway in primary human corneal epithelial cells.

Authors:  Yun Zhang; Ming Yang; Shi-Xin Zhao; Li Nie; Li-Jun Shen; Wei Han
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

5.  Efficacy of the Fluorescein Tear Breakup Time Test in Dry Eye.

Authors:  Jerry R Paugh; June Tse; Tiffany Nguyen; Alan Sasai; Elaine Chen; Melinda Thomas De Jesus; Justin Kwan; Andrew Loc Nguyen; Marjan Farid; Sumit Garg; James V Jester
Journal:  Cornea       Date:  2020-01       Impact factor: 3.152

6.  Altered mucins and aquaporins indicate dry eye outcome in patients undergoing Vitreo-retinal surgery.

Authors:  Ramalingam Mani; P S Shobha; Saravanan Thilagavathi; Padmanabhan Prema; Natarajan Viswanathan; Ratra Vineet; Ratra Dhanashree; Narayanasamy Angayarkanni
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

7.  Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease.

Authors:  Darrell E White; Yang Zhao; Hemalatha Jayapalan; Pattabhi Machiraju; Ramu Periyasamy; Abayomi Ogundele
Journal:  Clin Ophthalmol       Date:  2020-03-25

8.  Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease.

Authors:  Darrell E White; Yang Zhao; Hemalatha Jayapalan; Pattabhi Machiraju; Ramu Periyasamy; Abayomi Ogundele
Journal:  Clin Ophthalmol       Date:  2020-03-19

9.  Shift Work and Dry Eye Disease in the Korean Working Population: A Population-Based Cross-Sectional Study.

Authors:  Joonho Ahn; So-Jung Ryu; Jihun Song; Hyoung-Ryoul Kim
Journal:  Int J Environ Res Public Health       Date:  2021-05-20       Impact factor: 3.390

10.  Effect of acupuncture versus artificial tears for dry eye disease: A protocol for systematic review and meta-analysis.

Authors:  Hongjuan Fu; Junxiang Wang; Feng Zhang; Yong Tang; Hao Zhou; Chao Wang
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.